Provided by Tiger Trade Technology Pte. Ltd.

VIVA BIOTECH

1.370
-0.015-1.08%
Volume:4.11M
Turnover:5.59M
Market Cap:2.87B
PE:15.22
High:1.390
Open:1.390
Low:1.335
Close:1.385
52wk High:3.270
52wk Low:1.040
Shares:2.09B
HK Float Shares:2.09B
Volume Ratio:0.71
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.090
ROE:5.62%
ROA:1.71%
PB:0.62
PE(LYR):15.22
PS:1.29

Loading ...

Viva Biotech Holdings' (HKG:1873) Profits May Not Reveal Underlying Issues

Simply Wall St.
·
Apr 30

VIVA BIOTECH's Shares Nearly Halved in Three Months, Lagging Behind CXO Sector's Rebound

Stock News
·
Apr 27

VIVA BIOTECH 2025 ESG Report: Net Profit Up 21.30%, Carbon Emissions Cut 6%, AI-Driven Drug Discovery Unveiled

Bulletin Express
·
Apr 22

维亚生物2025年净利同比增至人民币2.693亿元,CRO与CDMO业务双线发力

Bulletin Express
·
Apr 22

Viva Biotech calls 26 June 2026 AGM; proposes 20 % share-issue mandate, 10 % buy-back limit and re-election of three directors

Bulletin Express
·
Apr 22

VIVA Biotech Holdings announces annual general meeting

Reuters
·
Apr 22

Viva Biotech publishes 2025 annual report

Reuters
·
Apr 22

Viva Biotech hosts webinar on AI and flow chemistry in drug synthesis scale-up

Reuters
·
Apr 21

Viva Biotech Files March 2026 Monthly Return: Share Capital Stable, 15.92 Million Options Outstanding

Bulletin Express
·
Apr 09

Viva Biotech Reports Stable Share Capital Structure for January 2026; 4.42 Million Post-IPO Options Lapse

Bulletin Express
·
Apr 09

Asian Penny Stocks To Consider In April 2026

Simply Wall St.
·
Apr 07

Viva Biotech Holdings (SEHK:1873) One Off Gain Clouds Trailing 12.7% Margin Narrative

Simply Wall St.
·
Apr 01

Stock Track | Viva Biotech Plummets 7.04% Intraday on Mixed 2025 Financial Results

Stock Track
·
Mar 31

Press Release: Viva Biotech Announces 2025 Annual Results: AI-Driven Drug Discovery Reinforces Industry Leadership, CDMO Commercial Products Enter Rapid Scale-Up

Dow Jones
·
Mar 30

Viva Biotech 2025 Results: Net Profit Jumps 21.30%, Margin Expansion Offsets Revenue Dip

Bulletin Express
·
Mar 30

VIVA BIOTECH Announces Annual Profit Increase of 21.31% to 269 Million Yuan

Stock News
·
Mar 30

VIVA Biotech FY25 net profit rises 21.3% to RMB 269 million; revenue drops 12.9% to RMB 1.7 billion

Reuters
·
Mar 30

VIVA Biotech Holdings FY Revenue RMB 1,729.4 Million

THOMSON REUTERS
·
Mar 30

Viva Biotech (01873) Schedules 30 Mar 2026 Board Meeting to Approve FY 2025 Results and Final Dividend Proposal

Bulletin Express
·
Mar 18

VIVA Biotech Holdings schedules board meeting to approve annual results and consider final dividend

Reuters
·
Mar 18